T2 Biosystems, Inc. Proceeds from Issuance Initial Public Offering
T2 Biosystems, Inc. reported Proceeds from Issuance Initial Public Offering of $33.68 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2016-03-09
- T2 Biosystems, Inc. proceeds from issuance initial public offering for the quarter ending 2015-03-31 was $375.00K.
- T2 Biosystems, Inc. proceeds from issuance initial public offering for the quarter ending 2014-12-31 was -$2.06M.
- T2 Biosystems, Inc. proceeds from issuance initial public offering for fiscal 2015 was $33.68M, a 42.03% decline from fiscal 2014.
- T2 Biosystems, Inc. proceeds from issuance initial public offering for fiscal 2014 was $58.09M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2015-12-31 | $33.68M 10-K · filed 2016-03-09 | |||
| 2015-03-31 | $375.00K 10-Q · filed 2015-05-06 | -$1.68M derived: sum of 2 quarters · filed 2016-03-09 | ||
| 2014-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $58.09M 10-K · filed 2016-03-09 | ||
| 2014-09-30 | $60.15M 10-Q · filed 2015-11-04 |